Abstract

The introduction of Nurse Independent Prescribing and Nurse Supplementary Prescribing means that over 10 000 nurses across the UK have virtually the same prescribing rights as doctors. Nurses are therefore faced with the challenges of working with the pharmaceutical industry. Such challenges include the extent to which promotional material can be relied upon, the acceptability with regards to the provision of free samples, hospitality, gifts, and the sponsorship of meetings. The Association of the British Pharmaceutical Industry (ABPI) Code of Practice for the Pharmaceutical Industry sets out how pharmaceutical companies are permitted to promote medicines to health professionals and others. It also covers the provision of information about prescription-only medicines to the public.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.